Christopher Y. Thomas

1.1k total citations
21 papers, 826 citations indexed

About

Christopher Y. Thomas is a scholar working on Surgery, Oncology and Molecular Biology. According to data from OpenAlex, Christopher Y. Thomas has authored 21 papers receiving a total of 826 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 11 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Christopher Y. Thomas's work include Bladder and Urothelial Cancer Treatments (3 papers), Oral and Maxillofacial Pathology (3 papers) and Head and Neck Cancer Studies (3 papers). Christopher Y. Thomas is often cited by papers focused on Bladder and Urothelial Cancer Treatments (3 papers), Oral and Maxillofacial Pathology (3 papers) and Head and Neck Cancer Studies (3 papers). Christopher Y. Thomas collaborates with scholars based in United States, Sweden and Finland. Christopher Y. Thomas's co-authors include Christopher A. Moskaluk, Patrick M. Dillon, Samhita Chakraborty, Stanley R. Friesen, Arlo S. Hermreck, Paul W. Read, Paul A. Levine, James F. Reibel, John A. Jane and Steven A. Newman and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Christopher Y. Thomas

21 papers receiving 800 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher Y. Thomas United States 13 483 366 174 147 143 21 826
Xiaoming Huang China 18 419 0.9× 183 0.5× 283 1.6× 247 1.7× 107 0.7× 86 986
Eric Lamarre United States 16 535 1.1× 374 1.0× 137 0.8× 202 1.4× 83 0.6× 87 977
F. Chiesa Italy 19 360 0.7× 405 1.1× 262 1.5× 204 1.4× 95 0.7× 41 1.1k
İnci̇ Ayan Türkiye 15 250 0.5× 250 0.7× 102 0.6× 285 1.9× 44 0.3× 44 708
Kumar Alok Pathak Canada 16 437 0.9× 246 0.7× 184 1.1× 105 0.7× 40 0.3× 47 987
Takahide Taguchi Japan 19 440 0.9× 413 1.1× 172 1.0× 345 2.3× 34 0.2× 86 1.0k
Pingzhang Tang China 14 342 0.7× 336 0.9× 104 0.6× 157 1.1× 83 0.6× 112 751
Wojciech K. Mydlarz United States 18 272 0.6× 430 1.2× 439 2.5× 133 0.9× 105 0.7× 45 1.2k
Gui Young Kwon South Korea 15 359 0.7× 161 0.4× 140 0.8× 137 0.9× 43 0.3× 23 736
Laura Marra Italy 17 157 0.3× 144 0.4× 270 1.6× 123 0.8× 69 0.5× 37 682

Countries citing papers authored by Christopher Y. Thomas

Since Specialization
Citations

This map shows the geographic impact of Christopher Y. Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Y. Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Y. Thomas more than expected).

Fields of papers citing papers by Christopher Y. Thomas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Y. Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Y. Thomas. The network helps show where Christopher Y. Thomas may publish in the future.

Co-authorship network of co-authors of Christopher Y. Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Y. Thomas. A scholar is included among the top collaborators of Christopher Y. Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Y. Thomas. Christopher Y. Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bitting, Rhonda L., Janet A. Tooze, Michael Goodman, et al.. (2024). Low-dose Paclitaxel with Pembrolizumab Enhances Clinical and Immunologic Responses in Platinum-refractory Urothelial Carcinoma. Cancer Research Communications. 4(2). 530–539. 3 indexed citations
2.
Bitting, Rhonda L., Janet A. Tooze, Christopher Y. Thomas, et al.. (2021). Single-arm phase II study of low-dose paclitaxel and pembrolizumab in platinum-refractory metastatic urothelial carcinoma (UC).. Journal of Clinical Oncology. 39(6_suppl). 433–433. 2 indexed citations
3.
Bitting, Rhonda L., Janet A. Tooze, Scott Isom, et al.. (2021). Phase I Study of Muscadine Grape Extract for Patients With Advanced Cancer. American Journal of Clinical Oncology. 44(6). 239–246. 10 indexed citations
4.
Dillon, Patrick M., Gina R. Petroni, Bethany J. Horton, et al.. (2017). A Phase II Study of Dovitinib in Patients with Recurrent or Metastatic Adenoid Cystic Carcinoma. Clinical Cancer Research. 23(15). 4138–4145. 65 indexed citations
5.
Dillon, Patrick M., Gina R. Petroni, Paula M. Fracasso, et al.. (2015). A phase II study of dovitinib in patients with recurrent or metastatic adenoid cystic carcinoma (ACC).. Journal of Clinical Oncology. 33(15_suppl). e17092–e17092. 4 indexed citations
6.
Dillon, Patrick M., et al.. (2014). Adenoid cystic carcinoma: A review of recent advances, molecular targets, and clinical trials. Head & Neck. 38(4). 620–627. 190 indexed citations
7.
Liu, Wennuan, Chunmei Xie, Christopher Y. Thomas, et al.. (2013). Genetic markers associated with early cancer‐specific mortality following prostatectomy. Cancer. 119(13). 2405–2412. 71 indexed citations
8.
Hollen, Patricia J., Richard J. Gralla, Randy Jones, et al.. (2012). A theory-based decision aid for patients with cancer: results of feasibility and acceptability testing of DecisionKEYS for cancer. Supportive Care in Cancer. 21(3). 889–899. 20 indexed citations
9.
Jameson, Mark J., et al.. (2012). Activation of the insulin‐like growth factor‐1 receptor alters p27 regulation by the epidermal growth factor receptor in oral squamous carcinoma cells. Journal of Oral Pathology and Medicine. 42(4). 332–338. 14 indexed citations
10.
Rahimi, Asal, Drew K. Saylor, Edward B. Stelow, et al.. (2012). p16, Cyclin D1, and HIF-1αPredict Outcomes of Patients with Oropharyngeal Squamous Cell Carcinoma Treated with Definitive Intensity-Modulated Radiation Therapy. SHILAP Revista de lepidopterología. 2012. 1–9. 14 indexed citations
11.
Jameson, Mark J., et al.. (2011). Activation of the Insulin-like Growth Factor-1 Receptor Induces Resistance to Epidermal Growth Factor Receptor Antagonism in Head and Neck Squamous Carcinoma Cells. Molecular Cancer Therapeutics. 10(11). 2124–2134. 69 indexed citations
12.
Sheng, Ke, Christopher A. Moskaluk, Christopher Y. Thomas, et al.. (2010). Intensity‐modulated radiotherapy outcomes for oropharyngeal squamous cell carcinoma patients stratified by p16 status. Cancer. 116(11). 2645–2654. 30 indexed citations
13.
Thomas, Christopher Y., Paul W. Read, Gina R. Petroni, James F. Reibel, & Paul A. Levine. (2009). Phase I study of capecitabine, carboplatin and intensity-modulated radiation therapy for head and neck cancer.. PubMed. 29(7). 2869–73. 3 indexed citations
14.
Reibel, James F., Paul W. Read, Christopher Y. Thomas, et al.. (2006). Esthesioneuroblastoma. Archives of Otolaryngology - Head and Neck Surgery. 132(2). 134–134. 129 indexed citations
15.
Thomas, Christopher Y. & Dan Theodorescu. (2006). Molecular markers of prognosis and novel therapeutic strategies for urothelial cell carcinomas. World Journal of Urology. 24(5). 565–578. 5 indexed citations
16.
Thomas, Christopher Y., Michael Chouinard, Michael Cox, et al.. (2003). Spontaneous activation and signaling by overexpressed epidermal growth factor receptors in glioblastoma cells. International Journal of Cancer. 104(1). 19–27. 43 indexed citations
17.
Thomas, Christopher Y., et al.. (1988). Mechanism of selection of class II recombinant murine leukemia viruses in the highly leukemic strain CWD. Journal of Virology. 62(4). 1158–1166. 9 indexed citations
18.
Thomas, Christopher Y.. (1974). Hyperbaric Oxygen Therapy for Pyoderma Gangrenosum. Archives of Dermatology. 110(3). 445–445. 25 indexed citations
19.
Hermreck, Arlo S., Christopher Y. Thomas, & Stanley R. Friesen. (1974). Importance of pathologic staging in the surgical management of adenocarcinoma of the exocrine pancreas. The American Journal of Surgery. 127(6). 653–657. 87 indexed citations
20.
Davis, Donald R. & Christopher Y. Thomas. (1961). Intramural Hematoma of the Duodenum and Jejunum. Annals of Surgery. 153(3). 394–398. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaoming Huang Breakdown of academic impact, for papers by Eric Lamarre Breakdown of academic impact, for papers by F. Chiesa Breakdown of academic impact, for papers by İnci̇ Ayan Breakdown of academic impact, for papers by Kumar Alok Pathak Breakdown of academic impact, for papers by Takahide Taguchi Breakdown of academic impact, for papers by Pingzhang Tang Breakdown of academic impact, for papers by Wojciech K. Mydlarz Breakdown of academic impact, for papers by Gui Young Kwon Breakdown of academic impact, for papers by Laura Marra
Rankless by CCL
2026